Xenogeneic Arterial Bypass Graft
1 R43 HL53192-01,
Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatofeasibility study in canine subjects to determine whether an immunologically modified xenogeneic vesendothelium can serve as a replacement of the autogenous saphenous vein. The investigators intend tothe tissue modification technique, and seek to optimize endothelial cell seeding. The final object oassess in vivo the biocompatibility of the implant, as well as its overall effectiveness as a graft.
Small Business Information at Submission:
Principal Investigator:Steven Goldstein
2211 New Market Parkway, Suite Marietta, GA 30067
Number of Employees: